NasdaqGM - Nasdaq Real Time Price USD
Axsome Therapeutics, Inc. (AXSM)
106.25
-1.83
(-1.69%)
At close: June 12 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-118,318
-128,410
-145,080
-116,511
-108,226
Investing Cash Flow
-510
-270
-582
-53,702
-308
Financing Cash Flow
88,297
57,840
331,013
284,582
11,130
End Cash Position
300,910
315,353
386,193
200,842
86,473
Interest Paid Supplemental Data
19,377
19,690
16,730
7,686
4,625
Capital Expenditure
-510
-270
-582
-702
-308
Issuance of Capital Stock
60,434
40,784
258,750
243,763
7,436
Issuance of Debt
--
0
85,000
45,000
0
Repayment of Debt
-1,228
-990
0
0
0
Free Cash Flow
-118,828
-128,680
-145,662
-117,213
-108,534
12/31/2021 - 11/19/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TGTX TG Therapeutics, Inc.
37.37
-2.48%
MDGL Madrigal Pharmaceuticals, Inc.
297.21
+0.98%
BBIO BridgeBio Pharma, Inc.
39.65
+1.54%
VERA Vera Therapeutics, Inc.
22.52
+1.90%
IOVA Iovance Biotherapeutics, Inc.
2.3100
+3.12%
VKTX Viking Therapeutics, Inc.
28.58
-1.28%
VRNA Verona Pharma plc
92.50
+2.72%
AKRO Akero Therapeutics, Inc.
53.56
+1.14%
ALT Altimmune, Inc.
7.15
+9.33%
URGN UroGen Pharma Ltd.
11.08
+51.78%